Cleared Traditional

K810593 - NEUROPAC ULTRA I

K810593 is an FDA 510(k) clearance for NEUROPAC ULTRA I, manufactured by Medical Devices, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 8-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1981
Decision
8d
Days
Class 2
Risk

K810593 is an FDA 510(k) clearance for the NEUROPAC ULTRA I. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Medical Devices, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 13, 1981 after a review of 8 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K810593

510(k) Number K810593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 1981
Decision Date March 13, 1981
Days to Decision 8 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
141d faster than avg
Panel avg: 149d · This submission: 8d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K810593.
MEDAID
K810841 · C.V.I., Inc. · Jun 1981
MINISTIM
K811224 · Medical Design & Manufacturing Corp. · Jun 1981
TENS-O-MATIC
K811012 · O-Matic, Inc. · Jun 1981
MENTOR 402 TRANSCUTANEOUS ELEC. STIMULAT
K803113 · George H. Frisch · Dec 1980
MENTOR 150 TRANSCUTANEOUS NERVE STIMULA
K803121 · George H. Frisch · Dec 1980
TRANSCUTANEOUS ELECTRIC NERVE STIMULATOR
K802678 · General Medical Industries, Inc. · Dec 1980